Kerry Gordon
About Kerry Gordon
Kerry Gordon serves as the R&D Process Development Lead at Watchmaker Genomics in Cape Town, South Africa, a position he has held since 2021. His extensive background includes roles at Roche and the University of Cape Town, where he focused on microbiology and biochemistry.
Work at Watchmaker Genomics
Kerry Gordon has been serving as the R&D Process Development Lead at Watchmaker Genomics since 2021. In this role, he is responsible for overseeing research and development processes within the organization. His work is based in Cape Town, Western Cape, South Africa, where he contributes to the advancement of genomic technologies.
Previous Experience at Roche
Prior to his current position, Kerry Gordon held multiple roles at Roche. He worked as the Head of Sample Preparation Reagents Research & Early Development for eight months in 2019. He also served as the Research & Early Development Team Lead for NGS Sample Preparation from 2016 to 2019 and as the Process Design Team Lead from 2020 to 2021. His tenure at Roche provided him with extensive experience in research and development in the biotechnology sector.
Academic Background
Kerry Gordon studied at the University of Cape Town, where he earned a BSc in Microbiology and Biochemistry from 1994 to 1996. He furthered his education with an MSc in Medical Biochemistry from 1999 to 2001 and completed his PhD in Medical Biochemistry from 2007 to 2011. His academic background laid the foundation for his career in research and development.
Experience in Academia
Kerry Gordon has a background in academia, having worked at the University of Cape Town as an Assistant Lecturer/Tutor from 2007 to 2011. Additionally, he served as a Post-doctoral Fellow from 2011 to 2013. These roles allowed him to engage in teaching and research, contributing to the academic community.
Role at Kapa Biosystems
At Kapa Biosystems, Kerry Gordon held the position of Senior R&D Scientist for three months in 2014. He also served as the R&D Team Leader for PCR/qPCR from 2014 to 2015. His work at Kapa Biosystems focused on advancing research and development in molecular biology techniques.